Right of Reference. Each Party hereby grants to the other a “right of reference,” as that term is defined in 21 C.F.R. § 314.3(b), to any data controlled by such Party that relates to any Product, and each Party shall provide a signed statement to this effect, if requested by the other Party, in accordance with 21 C.F.R. § 314.50(g)(3).
Appears in 2 contracts
Sources: License Agreement (Progenics Pharmaceuticals Inc), License and Co Development Agreement (Progenics Pharmaceuticals Inc)
Right of Reference. Each Party hereby grants to the other a “right "Right of referenceReference,” " as that term is defined in 21 C.F.R. § (S) 314.3(b), to any data controlled by such Party that relates to any Productdeveloped under this Agreement, and each a Party shall provide a signed statement to this effect, if requested by the other Partyother, in accordance with 21 C.F.R. § (S) 314.50(g)(3).
Appears in 2 contracts
Sources: Collaboration and License Agreement (Viropharma Inc), Collaboration and License Agreement (Viropharma Inc)
Right of Reference. Each Party hereby grants to the other a “right Right of referenceReference,” as that term is defined in 21 C.F.R. § 314.3(b), to any data controlled by such Party that relates to any Productdeveloped under this Agreement, and each a Party shall provide a signed statement to this effect, if requested by the other Partyother, in accordance with 21 C.F.R. § 314.50(g)(3).
Appears in 1 contract
Right of Reference. Each Party hereby grants to the other Party a “right Right of referenceReference,” as that term is defined in 21 C.F.R. § 314.3(b), to any data controlled Controlled by such Party or its Affiliates that relates to any ProductAgreement Compound or Product for which the other Party is the Lead Developer, and each such Party shall will provide a signed statement to this effect, if requested by the other Party, in accordance with 21 C.F.R. § 314.50(g)(3).
Appears in 1 contract
Sources: Research and License Agreement (Pharmacopeia Drug Discovery Inc)